STOCK OPTIONS (Details Narrative) - USD ($) $ / shares in Units, $ in Millions	1 Months Ended	12 Months Ended
	May 31, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Jan. 01, 2023	Oct. 31, 2020
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Options to purchase shares of common stock outstanding		14,838,000	12,473,000	9,503,000
Weighted average grant-date fair value of options granted		$ 3.37
Expected dividends		0.00%	0.00%	0.00%
Performance Shares [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Unvested options subject to vesting shares		1,235,000
Unrecognized compensation expense		$ 7.1
Time-Based Options [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Unvested options subject to vesting shares		5,986,000
Unrecognized compensation expense		$ 23.3
Unrecognized compensation expense recognition period		2 years 4 months 24 days
2017 Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Options to purchase shares of common stock outstanding		12,489,652
Option exercisable expiration period		10 years
Number of shares description		the number of shares available for issuance under the 2017 Plan in an amount equal to (1) the difference between (x) 18% of the total shares of the Company’s common stock outstanding, on a fully diluted basis, on December 31st of the preceding calendar year, and (y) the total number of shares of the Company’s common stock reserved under the 2017 Plan on December 31st of such preceding calendar year or (2) an amount less than this calculated increase as determined by the board of directors
Available for future grants shares		575,928
2017 Plan [Member] \| Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Available for future grants shares					7,186,283
2020 Inducement Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Options to purchase shares of common stock outstanding		2,348,717
Option exercisable expiration period		10 years
Available for future grants shares		2,151,283
Options other increases decreases in period	4,500,000					2,000,000
Number of shares available for issuance	2,500,000

Provention Bio, Inc. 10-K